Home » Topics » BioWorld Science

BioWorld Science
RSS

Medeva acquires Rochester business pipeline from RPR

June 14, 1996

Ascalon: Titan's newly formed subsidiary

June 14, 1996

Lilly/Merck-Medco Managed Care diabetes program development agreement

June 14, 1996

HemaSure/American Red Cross Biomedical Services alliance

June 14, 1996

Exelixis acquires rights to P Element technology

June 14, 1996

Bayer/CV Therapeutics antiinflammatory drug agreement

June 14, 1996

Bristol-Myers Squibb/Garvan Institute of Medical Research collaboration

June 14, 1996

Ingenex granted phase II SBIR grant

June 14, 1996

Lithium/nimodipine combination as bipolar I manic disorder treatment

June 14, 1996

Drug candidate for schizophrenia awaits clinical trials

June 14, 1996

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...